From the first reported cases of HIV in 1981 to the latest breakthroughs in long-acting prevention, this Spotlight timeline traces key moments in the global and South African response to the virus. It highlights scientific milestones, political controversies, activism, and the human stories that shaped one of the most significant public health challenges of our time.
South Africa has the world’s largest population of people living with HIV, which both heightens the risk of anal cancers and their severity. However, neither the collection of data nor the efforts for prevention and screening are in line with the likely impact. Experts say significant change is needed, reports Elna Schütz.
Spotlight has launched a new HIV dashboard and graph generator based on outputs from the Thembisa model. Our hope is that this dashboard will help the public and people working in healthcare to find important HIV numbers more easily. Please take a look and let us know what you think of it.
The number of HIV viral load tests is significantly lower than expected, according to an analysis of data from the National Health Laboratory Service which Spotlight and GroundUp obtained through the Promotion of Access to Information Act.
An HIV prevention jab that provides six months of protection at a time was given the green light by South Africa’s medicines regulator. The approval helps to clear the way for a limited public sector rollout of the “game-changing” shot set to start in April 2026.
A landmark ruling from the Supreme Court of Appeal means specially trained pharmacists will soon be allowed to dispense antiretrovirals without a doctor’s script. Pharmacists with the required training will need special permits from the director general of health. While no pharmacists yet hold these permits, Catherine Tomlinson reports that they may be able to start applying for them as soon as next month.
Ritshidze, South Africa’s powerhouse community-led healthcare monitor, is on the brink of shutting down. Experts warn its collapse could unravel years of progress in our clinics – just as worrying new data points to a decline in HIV services.
